SaigonBao.com

Archive -Daily News

CRISPR Therapy

CRISPR : 2022January16Sunday

JPM22: Aftershocks for Lilly, CRISPR versus CRISPR and Bluebird's crucial year - BioPharma Dive

Crispr Therapeutics' Giant Leap For Humankind - Seeking Alpha

First sickle cell patient treated with CRISPR gene-editing still thriving - NPR

Alternative functions of CRISPR–Cas systems in the evolutionary arms race - Nature.com

Technology company turns to CRISPR - World Grain

Scientists Used CRISPR Gene Editing to Choose the Sex of Mouse Pups - Singularity Hub

Decade after CRISPR discovery, unimaginable outcomes of gene editing emerge - Haaretz

CRISPR Gene Editing Market, 2031 - ResearchAndMarkets.com - Business Wire

The Best CRISPR Companies to Invest In - Motley Fool

Human Proteins Behind COVID-19 Infection Revealed by Innovative CRISPR Technology - UCSF News Services

Genetic Engineering: 2022January16Sunday

Nanotechnology strategies for plant genetic engineering - Nanowerk

Scientists Are Genetically Modifying Climate-Friendly Rice | Time - TIME

Rare De Novo Mutations Identified in Obsessive Compulsive Disorder Study - Genetic Engineering & Biotechnology News

USDA Genetic Engineered Food Label Misleads Consumers, Took Effect January 1 - Beyond Pesticides

Genetic strategy reverses insecticide resistance - Science Daily

Ryan Phelan: How gene technology can save species on the brink of extinction - NPR

Gene editing a 'polarizing' debate in organic production - Western Producer

First pig-to-human heart transplant: what can scientists learn? - Nature.com

Genome Editing/Genome Engineering Market Research Report 2021: Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application (Cell Line Engineering, Genetic Engineering, Diagnostics) - ResearchAndMarkets.com - Yahoo Finance

Triad high school students are learning how to edit genes - WFMYNews2.com

Gene Editing : 2022January16Sunday

Pfizer expands into gene editing with Beam research deal - BioPharma Dive

CRISPR Gene-Editing Technology Enters the Body — and Space - DISCOVER Magazine

First sickle cell patient treated with CRISPR gene-editing still thriving - NPR

JPM 2022: Editas, which caught flak in 2021 for limited gene editing data, will try to layer on the proof in 2022 - FierceBiotech

Synthetic viral lookalikes sneak gene-editing tools into cells - Nature.com

Scientists Used CRISPR Gene Editing to Choose the Sex of Mouse Pups - Singularity Hub

Global CRISPR Gene Editing Market Report 2021-2031: - GlobeNewswire

Gene editing among the winter classes for high school freshmen and sophomores at Salem Academy - Winston-Salem Journal

Next Generation Prime Gene Editing Systems Expands Technology’s Therapeutic and Research Applications - SciTechDaily

Gene editing a 'polarizing' debate in organic production - Western Producer

CRISPR Therapy : 2022January16Sunday

First sickle cell patient treated with CRISPR gene-editing still thriving - NPR

Bayer Strikes "Mammoth" CRISPR Deal to Bolster Cell and Gene Therapy - BioSpace

Pfizer buys into next-generation gene editing in $300 million deal with Beam Therapeutics - Chemical & Engineering News

The Best CRISPR Companies to Invest In - Motley Fool

Top ETFs Tracking CRISPR Gene Editing - Motley Fool

CRISPR Gene Editing Market, 2031 - ResearchAndMarkets.com - Business Wire

Is Beam Therapeutics a Good Stock to Buy Now? - Motley Fool

5 questions facing gene therapy in 2022 - BioPharma Dive

Decade after CRISPR discovery, unimaginable outcomes of gene editing emerge - Haaretz

JPM22: Aftershocks for Lilly, CRISPR versus CRISPR and Bluebird's crucial year - BioPharma Dive